Upregulation of efrAB efflux pump among Enterococcus faecalis ST480, ST847 in Iran.

Antibiotic resistance and especially multiresistance in Enterococci, is a serious public health issue especially in infections of immunocompromised patients. EfrAB is a heterodimeric multidrug ATP-binding cassette (ABC) transporter that causes endogenous resistance to antimicrobials including fluoroquinolones in Enterococcus spp. The aim of this study was to seek the gene expression rate and role of efrAB efflux pump in ciprofloxacin resistant Enterococcus faecalis and Multilocus Sequence Typing (MLST) of multiresistant isolates. Phenotypic and genotyping identification of 80 E. faecalis isolates were performed. Minimum inhibitory concentrations (MICs) to ciprofloxacin (CIP) were measured with and without carbonylcyanide 3-chlorophenylhydrazone (CCCP) by broth microdilution. After DNA extraction and sequencing for detection of efrA and efrB genes, the efrAB efflux positive isolates that were resistant to ciprofloxacin and showed decrease of ciprofloxacin MIC range were identified. Isolates that exhibited decrease in ciprofloxacin MIC range from two to ten folds were assessed for biofilm formation and finally, the expression levels of efrB, efrA genes were measured by quantitative Real-Time PCR (qRT-PCR). High rates of resistance to tetracycline and minocycline and low rates of resistance to the most antibiotics used in this study were detected. The results in this study indicated that the incidence of Multiple drug resistance (MDR) was 23.7% and all isolates that were resistant to ciprofloxacin revealed several degrees of overexpression in efrA and efrB genes. Our study found two ST480 and one ST847 in E. faecalis isolates. In conclusion, despite of low frequency of resistance to the most antibiotics and MDRs in our region, we found one ST480 isolate with resistance to eight antibiotics that also exists in other parts of the world.

[1]  X. Giannakopoulos,et al.  Impact of enterococcal urinary tract infections in immunocompromised - neoplastic patients. , 2019, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[2]  R. Hage,et al.  Emerging Antibiotic Resistance to Bacterial Isolates from Human Urinary Tract Infections in Grenada , 2019, Cureus.

[3]  Qi Wang,et al.  Molecular characteristics of oxazolidinone resistance in enterococci from a multicenter study in China , 2019, BMC Microbiology.

[4]  R. Bonnet,et al.  Emergence of optrA-mediated linezolid resistance in enterococci from France, 2006-16. , 2019, The Journal of antimicrobial chemotherapy.

[5]  Chunni Zhang,et al.  Distribution of the optrA gene in Enterococcus isolates at a tertiary care hospital in China. , 2019, Journal of global antimicrobial resistance.

[6]  P. Lak,et al.  First detection of efrAB, an ABC multidrug efflux pump in Enterococcus faecalis in Tehran, Iran. , 2018, Acta microbiologica et immunologica Hungarica.

[7]  D. Anderson,et al.  Enhanced disinfection leads to reduction of microbial contamination and a decrease in patient colonization and infection , 2018, Infection Control & Hospital Epidemiology.

[8]  T. Perera,et al.  Vancomycin-Resistant Enterococci (VRE) , 2018 .

[9]  T. Shirakawa,et al.  International Comparison of Causative Bacteria and Antimicrobial Susceptibilities of Urinary Tract Infections between Kobe, Japan, and Surabaya, Indonesia. , 2018, Japanese journal of infectious diseases.

[10]  M. Pfaller,et al.  ZAAPS Program results for 2015: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 32 countries , 2017, The Journal of antimicrobial chemotherapy.

[11]  F. Moges,et al.  Isolation of enterococci, their antimicrobial susceptibility patterns and associated factors among patients attending at the University of Gondar Teaching Hospital , 2017, BMC Infectious Diseases.

[12]  D. Tieleman,et al.  The Heterodimeric ABC Transporter EfrCD Mediates Multidrug Efflux in Enterococcus faecalis , 2016, Antimicrobial Agents and Chemotherapy.

[13]  A. Boudabous,et al.  Diversity of enterococcal species and characterization of high-level aminoglycoside resistant enterococci of samples of wastewater and surface water in Tunisia. , 2015, The Science of the total environment.

[14]  M. Pourshafie,et al.  Antibiotic Resistance and Biofilm Formation of Enterococcus faecalis in Patient and Environmental Samples , 2015, Jundishapur journal of microbiology.

[15]  P. Gutiérrez-Castrellón,et al.  [Efficacy and safety of ciprofloxacin treatment in urinary tract infections (UTIs) in adults: a systematic review with meta-analysis]. , 2015, Gaceta medica de Mexico.

[16]  X. Shang,et al.  Urinary tract infection caused by Enterococcus isolates: aetiology and antimicrobial resistance patterns , 2015, Journal of chemotherapy.

[17]  N. Benomar,et al.  Role of EfrAB efflux pump in biocide tolerance and antibiotic resistance of Enterococcus faecalis and Enterococcus faecium isolated from traditional fermented foods and the effect of EDTA as EfrAB inhibitor. , 2014, Food microbiology.

[18]  A. Lo Nostro,et al.  Prevalence and antibiotic resistance of Enterococcus spp. isolated from retail cheese, ready-to-eat salads, ham, and raw meat. , 2014, Food microbiology.

[19]  So-Jung Kang,et al.  Distribution of Multidrug Efflux Pump Genes in Enterococci spp. Isolated from Bovine Milk Samples and Their Antibiotic Resistance Patterns , 2013 .

[20]  Gilho Lee Ciprofloxacin Resistance in Enterococcus faecalis Strains Isolated From Male Patients With Complicated Urinary Tract Infection , 2013, Korean journal of urology.

[21]  N. Benomar,et al.  Phenotypic and molecular antibiotic resistance profile of Enterococcus faecalis and Enterococcus faecium isolated from different traditional fermented foods. , 2013, Foodborne pathogens and disease.

[22]  A. Sundsfjord,et al.  Insight into antimicrobial susceptibility and population structure of contemporary human Enterococcus faecalis isolates from Europe. , 2012, The Journal of antimicrobial chemotherapy.

[23]  T. Shirakawa,et al.  Mechanisms of and Risk Factors for Fluoroquinolone Resistance in Clinical Enterococcus faecalis Isolates from Patients with Urinary Tract Infections , 2011, Journal of Clinical Microbiology.

[24]  P. Sorgeloos,et al.  Alternatives to antibiotics for the control of bacterial disease in aquaculture. , 2011, Current opinion in microbiology.

[25]  M. Yasuda,et al.  Nationwide survey of antibacterial activity against clinical isolates from urinary tract infections in Japan (2008). , 2011, International journal of antimicrobial agents.

[26]  Clsi Performance Standards for Antimicrobial Susceptibility Testing: Twenty-First Informational Supplement , 2010 .

[27]  V. Ferreira,et al.  Antibiotic susceptibility of enterococci isolated from traditional fermented meat products. , 2009, Food microbiology.

[28]  A. Afifi,et al.  Prevalence of Multidrug Resistant Enterococci in Nosocomial Infection In Gaza Strip , 2008 .

[29]  A. Driessen,et al.  Distribution and Physiology of ABC-Type Transporters Contributing to Multidrug Resistance in Bacteria , 2007, Microbiology and Molecular Biology Reviews.

[30]  Oliver Hendricks,et al.  Reversal of resistance in microorganisms by help of non-antibiotics. , 2007, The Journal of antimicrobial chemotherapy.

[31]  A. Hasan,et al.  Resistance patterns of urinary isolates in a tertiary Indian hospital. , 2007, Journal of Ayub Medical College, Abbottabad : JAMC.

[32]  Janetta Top,et al.  Multilocus Sequence Typing Scheme for Enterococcus faecalis Reveals Hospital-Adapted Genetic Complexes in a Background of High Rates of Recombination , 2006, Journal of Clinical Microbiology.

[33]  D. Levine,et al.  Vancomycin: a history. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  H. Schweizer,et al.  Bacterial resistance to antibiotics: active efflux and reduced uptake. , 2005, Advanced drug delivery reviews.

[35]  Arto S. Baghdayan,et al.  Enterococcal Surface Protein, Esp, Enhances Biofilm Formation by Enterococcus faecalis , 2004, Infection and Immunity.

[36]  R. Wenzel,et al.  Annals of Clinical Microbiology and Antimicrobials Open Access Emerging Resistance among Bacterial Pathogens in the Intensive Care Unit – a European and North American Surveillance Study (2000–2002) Intensive-care Unitantibiotic Susceptibility , 2022 .

[37]  T. Tsuchiya,et al.  EfrAB, an ABC Multidrug Efflux Pump in Enterococcus faecalis , 2003, Antimicrobial Agents and Chemotherapy.

[38]  M. Gilmore,et al.  Antibiotic-resistant enterococci: the mechanisms and dynamics of drug introduction and resistance. , 2002, Microbes and infection.

[39]  L. Mandell,et al.  Safety of fluoroquinolones: An update. , 2002, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

[40]  K. Lewis In search of natural substrates and inhibitors of MDR pumps. , 2001, Journal of molecular microbiology and biotechnology.

[41]  G. Weinstock,et al.  Enterococcus faecalis multi-drug resistance transporters: application for antibiotic discovery. , 2001, Journal of molecular microbiology and biotechnology.

[42]  M. Gilmore,et al.  Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. , 1998, Emerging infectious diseases.

[43]  M. Saier,et al.  Two novel families of bacterial membrane proteins concerned with nodulation, cell division and transport , 1994, Molecular microbiology.

[44]  R. Kolter,et al.  ABC transporters: bacterial exporters , 1993, Microbiological reviews.

[45]  C. Higgins,et al.  ABC transporters: from microorganisms to man. , 1992, Annual review of cell biology.

[46]  S. Levy,et al.  Active efflux mechanisms for antimicrobial resistance , 1992, Antimicrobial Agents and Chemotherapy.